Dermal absorption and tissue disposition of 3,3′,4,4′-tetrachlorobiphenyl (TCB) in an ex-vivo pig model: Assessing the impact of dermal exposure variables

International Journal of Occupational and Environmental Health

Volumn 6, Issue 2, 2000, Pages 127-137

  Qiao, Guilin ^a   Riviere, Jim E ^b  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

3,3 ,4,4 tetrachloro biphenyl (TCB); Exposure variables; Percutaneous absorption; Polychlorinated biphenyls (PCBs); Skin

Indexed keywords

3,3',4,4' TETRACHLOROBIPHENYL;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS SOLUTION; ARTICLE; CONTAMINATION; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; NONHUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIZATION; SKIN ABSORPTION; SKIN PENETRATION; SWINE; TISSUE DISTRIBUTION;

ANIMALS; FEMALE; LINEAR MODELS; PHARMACOKINETICS; POLYCHLORINATED BIPHENYLS; SKIN; SKIN ABSORPTION; SOIL POLLUTANTS; SWINE; VEHICLES;

EID: 0034068858     PISSN: 10773525     EISSN: None     Source Type: Journal    
DOI: 10.1179/oeh.2000.6.2.127     Document Type: Article

References (51)

1. Hinz R, Lorence C, Hodson C, Hansch C, Hall L, Guy R. Percutaneous penetration of para-substituted phenols in vitro. Fundam Appl Toxicol 1991;17:575-83.
2. World Health Organization. Environmental Health Criteria 140: Polychlorinated Biphenols and Terphenyls. 2nd ed. Geneva, Switzerland: WHO, 1993.
3. Wolff M. Occupational exposure to polychlorinated biphenyls (PCBs). Environ Health Perspect. 1985;60:133-8.
4. Safe S. Toxicology, structure-function relationship, and human and environmental health impacts of polychlorinated biphenyls: progress and problems. Environ Health Perspect. 1993;100:259-68.
5. De Vito M, Maier W, Diliberto J, Birnbaum L. Comparative ability of various PCBs, PCDFs, and TCDD to induce cytochrome P450 1A1 and 1A2 activity following 4 weeks of treatment. Fundam Appl Toxicol. 1993;20:125-30.
6. Garner C, Jefferson W, Burka L, Matthews H, Newbold R. In vitro estrogencitiy of the catechol metabolites of selected polychlorinated biphenyls. Toxicol Appl Pharmacol. 1999;154:188-97.
7. Jackson J, Diliberto J, Birnbaum L. Estimation of octanol-water partition coefficients and correlation with dermal absorption for several polyhalogenated aromatic hydrocarbons. Fundam Appl Toxicol. 1993;21:334-44.
8. Brown J Jr, Lawton R, Morgan C. PCB metabolism, persistence, and health effects after occupational exposure: implications for risk assessment. Chemosphere. 1994;29:2287-94.
9. Garner C, Matthews H. The effect of chlorine substitution on the dermal absorption of polychlorinated biphenyls. Toxicol Appl Pharmacol. 1998;149:150-8.
10. Wester R, Maibach H, Sedik L, Melendres J, Wade M. Percutaneous absorption of PCBs from soil: in vivo rhesus monkey, in vitro human skin, and binding to powdered human stratum corneum. J Toxicol Environ Health. 1993,39:375-82.
11. Qiao G, Riviere J. Impacts of dermal model and exposure variables on risk assessment of 3,3′,4,4′-tetrachlorobiphenyl (TCB). Toxicol Sci. 1998;42:390.
12. Bandiera S, Safe S, Okey A. Binding of polychlorinated biphenyls classified as eidier phenobarbitone-, 3-methylcholanthrene- or mixed-type inducers to cytosolic Ah receptor. Chem Biol Interact. 1982;39:259-77.
13. Safe S. Polychlorinated biphenyls (PCBs): mutagenicity and carcinogencity. Mutat Res. 1989;220:31-17.
14. Bartek M, Labudde J, Maibach H. Skin permeability in vivo: Comparison in rat, rabbit, pig and man. J Invest Dermatol. 1972;58:114-23.
15. 14C] parathion in vivo pigs. Toxicol Appl Pharmacol. 1993;122:131-8.
16. Reifenrath W, Hawkins G. The weanling Yorkshire pig as an animal model for measuring percutaneous penetration. In: Tumbelson ME (ed). Swine in Biomedical Research. New York: Plenum, 1986.673-80.
17. Monteiro-Riviere N, Stromberg M. Ultrastructure of the integument of the domestic pig (Sus scrofa) from one through fourteen weeks of age. Anat Histol Embryol. 1985;14:97-115.
18. Carver M, Riviere J. Percutaneous absorption and excretion of xenobiotics after topical and intravenous administration to pigs. Fundam Appl Toxicol. 1989;13:714-22.
19. Qiao G, Brooks J, Riviere J. Pentachlorophenol dermal absorption and disposition from soil in swine: effects of occlusion and skin microorganism inhibition. Toxicol Appl Pharmacol. 1997;147:234-46.
20. Qiao G, Brooks J, Baynes R, Monteiro-Riviere N, Williams P, Riviere J. The use of mechanistically-defined chemical mixtures (MDCM) to assess mixture component effects on the percutaneous absorption and cutaneous disposition of topically-exposed chemicals: I. Studies with parathion mixture in isolated perfused porcine skin. Toxicol Appl Pharmacol. 1996;141:473-86.
21. Reifenrath W, Chellquist E, Shipwash E, Jederberg W, Krueger G. Percutaneous penetration in the hairless dog, weanling pig and grafted athymic nude mouse: evaluation of models for predicting skin penetration in man. Br J Dermatol. 1984;3:123-35.
22. Riviere J, Monteiro-Riviere N, Inman A. Determination of Iidocaine concentration in skin after transdermal iontophoresis: effects of vasoactive drugs. Pharmacol Res. 1992,9:211-4.
23. Riviere J, Bowman K, Monteiro-Riviere N, Dix L, Carver M. The isolated perfused porcine skin flap (IPPSF). I. A novel in vitro model for percutaneous absorption and cutaneous toxicology studies. Fundam Appl Toxicol. 1986;7:444-53.
24. Hughes M, Shrivastava S, Sumler M, et al. Dermal absorption of chemicals: effect of application of chemicals as a solid, aqueous paste, suspension, or in volatile vehicle. J Toxicol Environ Health. 1992;37:57-71.
25. Calabrese E. Principles of Animal Extrapolation. Chelsea, MI: Lewis Publications, 1991:55-69.
26. Hansch C, Leo A, Hoekman D. Exploring QSAR: Hydrophonic Electronic and Steric Constants. Washington, DC: American Chemical Society, 1995:348.
27. Bronaugh R, Stewart R, Storm J. Extent of cutaneous metabolism during percutaneous absorption of xenobiotics. Toxicol Appl Pharmacol. 1989,99.534-43.
28. Collier S, Sheikh N, Sakr A, Lichtin J, Stewart R, Bronaugh R. Maintenance of skin viability during in vitro percutaneous absorption/metabolism studies. Toxicol Appl Pharmacol. 1989;99.522-33.
29. Bronaugh R, Stewart R, Congdon E, Giles, Riviere J, Inman A. Methods for in vitro percutaneous absorption studies. I. Comparison with in vivo results. Toxicol Appl Pharmacol. 1982;62:474-80.
30. Guy R, Hadgraft J. Prediction of drug disposition kinetics in skin and plasma following topical administration. J Pharmacol Sci. 1984;73:883-7.
31. Hawkins G, Reifenrath W. Development of an in vitro model for determining the fate of chemicals applied to skin. Fundam Appl Toxicol. 1984;4:S133-S144.
32. Franz T. Kinetics of cutaneous drug penetration. Int J Dermatol. 1983;22:499-505.
33. Surbe C, Wilhelm K, Hori M, Maibach H, Guy R. Optimization of topical therapy: partitioning of drug into stratum corneum. Pharmacol Res. 1990;7:1320-4.
34. Qiao G, Williams P, Riviere J. Percutaneous absorption, biotransformation and systemic disposition of parathion in vivo in swine. I. Comprehensive pharmacokinetic model. Drug Metab Dispos. 1994;23:459-71.
35. Bronaugh R, Barton C. Prediction of human percutaneous absorption with physiocchemical data. In: Wang RCM (ed). Health Risk Assessment - Dermal and Inhalation Exposure and Absorption of Toxicants. Boston, MA: CRC Press, 1993:117-26.
36. Elias P. Advances in Lipid Research. Vol. 24: Skin Lipids. Orlando, FL: Academic Press, 1991.
37. Potts R, Francoeyr M. Physical methods for studying stratum corneum lipids (review). Semin Dermatol. 1992;11:129-38.
38. Potts R, Golden G, Franceour M, Mak V, Guy R. Mechanism and enhancement of solute transport across the stratum corneum. J Contr Rel. 1991;15.249-60.
39. Potts R, McNeill S, Desbournet C, Wakskull E. Transdermal drug transport and metabolism. II. The role of competing kinetic events. Pharmacol Res. 1989,6:119-26.
40. Surber C, Wilhelm K, Maibach H, Hall L, Guy R. Partitioning of chemicals into human stratum corneum: implications for risk assessment following dermal exposure. Fundam Appl Toxicol 1990;15:99-107.
41. Yoshikawa K, Adachi K, Halprin K, Levine V. Effects of short chain alcohols and hydrocarbon compounds on the adenylate cyclase of the skin. Br J Dermatol. 1976,94:611-4.
42. Man M, Feingold R, Elias P. Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin. Arch Dermatol. 1993;129:728-38.
43. Wester R, Maibach H, Bucks D, et al. Percutaneous absorption and skin decontamination of PCBs: in vitro studies with human skin and in vivo studies in the rhesus monkey. J Toxicol Environ Healdi. 1990,31:235-46.
44. Williams P, Riviere J. A biophysically based dermatopharmacokinetic compartment model for quantifying percutaneous penetration and absorption of topically applied agent. I. Theory. J Pharmacol Sci. 1995;599-608.
45. Brooks J, Riviere J. Quantitative percutaneous absorption and cutaneous distribution of binary mixtures of phenol and paranitrophenol in isolated perfused porcine skin. Fundam Appl Toxicol. 1996;32:233-43.
46. Qiao G, Brooks J, Inman A, et al. Dose formulation effects on an experimental model. Differences in dermal absorption and tissue disposition of pentachlorophenol (PCP): in vivo, ex vivo, and in vitro studies. Pharmacol Res. 1996;13.S417.
47. Moody R, Wester R, Melendres J, Maibach H. Dermal absorption of the phenoxy herbicide 2,4-D dimethylamine in humans: effect of DEET and anatomic site. J Toxicol Environ Health. 1992;36:241-50.
48. World Health Organization. Chlorophenols other than pentachlorophenol. Geneva, Switzerland: WHO, 1989.97-155.
49. Baynes R, Brownie C, Freeman H, Riviere J. In vitro percutaneous absorption of benzidine in complex mechanistically defined chemical mixtures. Toxicol Appl Pharmacol. 1996;141:497-506.
50. Bunge A, Park J. Predicting dermal absorption from contact with chemically contaminated soils. In: Dwyer FJ, Doane TR, Hinman ML (eds). Environmental Toxicology and Risk Assessment: Modeling and Risk Assessment. 6th vol. Philadelphia, PA. ASTM STP 1317, 1997:227-44.
51. Qiao G, Riviere J. Significant effects of application site and occlusion on the pattern of cutaneous penetration and biotransformation of Parathion in vivo in swine. J Pharmacol Sci. 1995;84:425-32.